{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:55:52Z","timestamp":1791248152568,"version":"4.1.0"},"reference-count":291,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":723,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1111\/apt.12470","type":"journal-article","created":{"date-parts":[[2013,9,9]],"date-time":"2013-09-09T02:53:51Z","timestamp":1378695231000},"page":"887-913","source":"Crossref","is-referenced-by-count":151,"title":["Review article: autoimmune hepatitis - current management and challenges"],"prefix":"10.1111","volume":"38","author":[{"given":"K.","family":"Zachou","sequence":"first","affiliation":[{"name":"Department of Medicine and Research Laboratory of Internal Medicine; Medical School; Thessaly University; Larissa Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Muratori","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences; Alma Mater Studiorum - University of Bologna; Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. K.","family":"Koukoulis","sequence":"additional","affiliation":[{"name":"Department of Pathology; Medical School; Thessally University; Larissa Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Granito","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences; Alma Mater Studiorum - University of Bologna; Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Gatselis","sequence":"additional","affiliation":[{"name":"Department of Medicine and Research Laboratory of Internal Medicine; Medical School; Thessaly University; Larissa Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fabbri","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences; Alma Mater Studiorum - University of Bologna; Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. N.","family":"Dalekos","sequence":"additional","affiliation":[{"name":"Department of Medicine and Research Laboratory of Internal Medicine; Medical School; Thessaly University; Larissa Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Muratori","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences; Alma Mater Studiorum - University of Bologna; Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,9,8]]},"reference":[{"key":"10.1111\/apt.12470-BIB0001|apt12470-cit-0001","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/apt.12470-BIB0002|apt12470-cit-0002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0953-6205(02)00089-4","article-title":"Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview","volume":"13","author":"Dalekos","year":"2002","journal-title":"Eur J Intern Med"},{"key":"10.1111\/apt.12470-BIB0003|apt12470-cit-0003","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-2423(05)40004-9","article-title":"Autoantibodies in autoimmune liver disease","volume":"40","author":"Czaja","year":"2005","journal-title":"Adv Clin Chem"},{"key":"10.1111\/apt.12470-BIB0004|apt12470-cit-0004","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0005|apt12470-cit-0005","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0006|apt12470-cit-0006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0007|apt12470-cit-0007","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1089-3261(02)00021-1","article-title":"Prevalence and epidemiology of autoimmune hepatitis","volume":"6","author":"Boberg","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1111\/apt.12470-BIB0008|apt12470-cit-0008","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1440-1746.2003.03165.x","article-title":"Epidemiology of autoimmune liver disease","volume":"18","author":"Feld","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0009|apt12470-cit-0009","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study","volume":"43","author":"Werner","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0010|apt12470-cit-0010","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska Natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0011|apt12470-cit-0011","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population-based epidemiology study of autoimmune hepatitis: a disease of older women?","volume":"25","author":"Ngu","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0012|apt12470-cit-0012","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/j.1572-0241.2001.05272.x","article-title":"Autoimmune hepatitis in African Americans: presenting features and response to therapy","volume":"96","author":"Lim","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0013|apt12470-cit-0013","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MCG.0b013e318228b781","article-title":"The impact of race\/ethnicity on the clinical epidemiology of autoimmune hepatitis","volume":"46","author":"Wong","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0014|apt12470-cit-0014","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1023\/A:1020166605016","article-title":"Genetic bases of autoimmune hepatitis","volume":"47","author":"Czaja","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1111\/apt.12470-BIB0015|apt12470-cit-0015","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3748\/wjg.v11.i12.1862","article-title":"Genetic distinctions between autoimmune hepatitis in Italy and North America","volume":"11","author":"Muratori","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0016|apt12470-cit-0016","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-0528.2002.017401.x","article-title":"Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis","volume":"174","author":"Czaja","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1111\/apt.12470-BIB0017|apt12470-cit-0017","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.510300611","article-title":"Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition","volume":"30","author":"Pando","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0018|apt12470-cit-0018","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0168-8278(02)00182-4","article-title":"Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States","volume":"37","author":"Czaja","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0019|apt12470-cit-0019","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12470-BIB0020|apt12470-cit-0020","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1111\/apt.12470-BIB0021|apt12470-cit-0021","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","article-title":"Cytochrome P4502D6 (193-212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/apt.12470-BIB0022|apt12470-cit-0022","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2174\/092986708785747508","article-title":"Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450","volume":"15","author":"Bogdanos","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1111\/apt.12470-BIB0023|apt12470-cit-0023","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gut.46.4.553","article-title":"Liver\/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane","volume":"46","author":"Muratori","year":"2000","journal-title":"Gut"},{"key":"10.1111\/apt.12470-BIB0024|apt12470-cit-0024","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","article-title":"Human FoxP3+ regulatory T cells in systemic autoimmune diseases","volume":"10","author":"Miyara","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1111\/apt.12470-BIB0025|apt12470-cit-0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0026|apt12470-cit-0026","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/apt.12470-BIB0027|apt12470-cit-0027","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0028|apt12470-cit-0028","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1074\/mcp.M112.018713","article-title":"Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis","volume":"11","author":"Zingaretti","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.1111\/apt.12470-BIB0029|apt12470-cit-0029","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1586\/egh.10.42","article-title":"Animal models of autoimmune hepatitis","volume":"4","author":"Czaja","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0030|apt12470-cit-0030","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2010.05.075","article-title":"Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis","volume":"139","author":"Zierden","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12470-BIB0031|apt12470-cit-0031","first-page":"3644","article-title":"The CYP2D6 animal model: how to induce autoimmune hepatitis in mice","volume":"60","author":"Hintermann","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1111\/apt.12470-BIB0032|apt12470-cit-0032","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.20109","article-title":"A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens","volume":"39","author":"Lapierre","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0033|apt12470-cit-0033","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/hep.23536","article-title":"Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis","volume":"51","author":"Lapierre","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0034|apt12470-cit-0034","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.26023","article-title":"Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis mouse model restores peripheral tolerance","volume":"57","author":"Lapierre","year":"2013","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0035|apt12470-cit-0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2012.11.001","article-title":"Molecular mimicry rather than identity breaks T cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis","volume":"42","author":"Ehser","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1111\/apt.12470-BIB0036|apt12470-cit-0036","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection","volume":"205","author":"Holdener","year":"2008","journal-title":"J Exp Med"},{"key":"10.1111\/apt.12470-BIB0037|apt12470-cit-0037","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","article-title":"Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling","volume":"135","author":"Kido","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12470-BIB0038|apt12470-cit-0038","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0039|apt12470-cit-0039","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00535-011-0421-y","article-title":"Present status of autoimmune hepatitis in Japan: a nationwide survey","volume":"46","author":"Abe","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0040|apt12470-cit-0040","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1872-034X.2011.00808.x","article-title":"Acute presentation of autoimmune hepatitis: does it exist? A published work review","volume":"41","author":"Takahashi","year":"2011","journal-title":"Hepatol Res"},{"key":"10.1111\/apt.12470-BIB0041|apt12470-cit-0041","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/hch072","article-title":"Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the \u2018acute\u2019 type","volume":"97","author":"Ferrari","year":"2004","journal-title":"QJM"},{"key":"10.1111\/apt.12470-BIB0042|apt12470-cit-0042","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2036.2006.02894.x","article-title":"Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases","volume":"23","author":"Miyake","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0043|apt12470-cit-0043","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jhep.2009.01.020","article-title":"Autoimmune hepatitis in Italy: the Bologna experience","volume":"50","author":"Muratori","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0044|apt12470-cit-0044","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2036.2006.03013.x","article-title":"Clinical features of Japanese male patients with type 1 autoimmune hepatitis","volume":"24","author":"Miyake","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0045|apt12470-cit-0045","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2036.2006.03104.x","article-title":"Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study","volume":"24","author":"Floreani","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0046|apt12470-cit-0046","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1572-0241.2001.03782.x","article-title":"Autoimmune hepatitis in the elderly","volume":"96","author":"Schramm","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0047|apt12470-cit-0047","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2005.02488.x","article-title":"Clinical features of type 1 autoimmune hepatitis in elderly Italian patients","volume":"21","author":"Granito","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0048|apt12470-cit-0048","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","article-title":"Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre","volume":"45","author":"Al-Chalabi","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0049|apt12470-cit-0049","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2036.2005.02403.x","article-title":"Diagnosis and treatment of autoimmune hepatitis at age 65 and older","volume":"21","author":"Verslype","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0050|apt12470-cit-0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0051|apt12470-cit-0051","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-na\u00efve patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0052|apt12470-cit-0052","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2008.01904.x","article-title":"Features and consequences of untreated autoimmune hepatitis","volume":"29","author":"Czaja","year":"2009","journal-title":"Liver Int"},{"key":"10.1111\/apt.12470-BIB0053|apt12470-cit-0053","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/gut.48.1.97","article-title":"Management and outcome of pregnancy in autoimmune hepatitis","volume":"48","author":"Heneghan","year":"2001","journal-title":"Gut"},{"key":"10.1111\/apt.12470-BIB0054|apt12470-cit-0054","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1111\/j.1572-0241.2002.07124.x","article-title":"Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery","volume":"97","author":"Buchel","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0055|apt12470-cit-0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jaut.2011.12.002","article-title":"Outcomes of pregnancy in women with autoimmune hepatitis","volume":"38","author":"Westbrook","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1111\/apt.12470-BIB0056|apt12470-cit-0056","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S1590-8658(02)80098-6","article-title":"Spontaneous remission of autoimmune hepatitis during pregnancy","volume":"34","author":"Muratori","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1111\/apt.12470-BIB0057|apt12470-cit-0057","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","author":"Zachou","year":"2004","journal-title":"J Autoimmune Dis"},{"key":"10.1111\/apt.12470-BIB0058|apt12470-cit-0058","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1111\/apt.12470-BIB0059|apt12470-cit-0059","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1752-1947-4-311","article-title":"Autoimmune hepatitis triggered by nitrofurantoin: a case series","volume":"4","author":"Appleyard","year":"2010","journal-title":"J Med Case Rep"},{"key":"10.1111\/apt.12470-BIB0060|apt12470-cit-0060","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-Induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0061|apt12470-cit-0061","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0062|apt12470-cit-0062","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.dld.2011.11.003","article-title":"Severe acute autoimmune hepatitis after natalizumab treatment","volume":"44","author":"Lisotti","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1111\/apt.12470-BIB0063|apt12470-cit-0063","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1002\/ibd.21880","article-title":"Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate","volume":"17","author":"Subramaniam","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/apt.12470-BIB0064|apt12470-cit-0064","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1086\/524082","article-title":"De novo autoimmune hepatitis during immune reconstitution in an HIV-infected patient receiving highly active antiretroviral therapy","volume":"46","author":"O'Leary","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/apt.12470-BIB0065|apt12470-cit-0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1568-9972(03)00053-3","article-title":"Is there a role for viruses in triggering autoimmune hepatitis?","volume":"3","author":"Vento","year":"2004","journal-title":"Autoimmunity Rev"},{"key":"10.1111\/apt.12470-BIB0066|apt12470-cit-0066","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(95)91438-2","article-title":"Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals","volume":"346","author":"Vento","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/apt.12470-BIB0067|apt12470-cit-0067","doi-asserted-by":"crossref","first-page":"bcr0620080071","DOI":"10.1136\/bcr.06.2008.0071","article-title":"Autoimmune hepatitis following Epstein-Barr virus infection","volume":"2008","author":"Cabibi","year":"2008","journal-title":"BMJ Case Rep"},{"key":"10.1111\/apt.12470-BIB0068|apt12470-cit-0068","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2177\/jsci.28.154","article-title":"A case of autoimmune hepatitis needed to be differentiated from EBV hepatitis, in that the histology of liver biopsy specimen was useful for diagnosis","volume":"28","author":"Nakajima","year":"2005","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1111\/apt.12470-BIB0069|apt12470-cit-0069","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1665-2681(19)31398-5","article-title":"Autoimmune hepatitis type-2 and Epstein-Barr virus infection in a toddler: art of facts or an artifact?","volume":"12","author":"Zellos","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1111\/apt.12470-BIB0070|apt12470-cit-0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jhep.2003.10.022","article-title":"De novo autoimmune hepatitis after liver transplantation","volume":"40","author":"Mieli-Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0071|apt12470-cit-0071","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MOT.0b013e3283536622","article-title":"Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation","volume":"17","author":"Fiel","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/apt.12470-BIB0072|apt12470-cit-0072","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5414\/CNP70245","article-title":"A case of membranous nephropathy associated with Sj\u00f6gren syndrome, polymyositis and autoimmune hepatitis","volume":"70","author":"Stefanidis","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1111\/apt.12470-BIB0073|apt12470-cit-0073","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1053\/gast.2001.27103","article-title":"Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"121","author":"Obermayer-Straub","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12470-BIB0074|apt12470-cit-0074","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.cca.2012.05.015","article-title":"IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases","volume":"413","author":"Gatselis","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1111\/apt.12470-BIB0075|apt12470-cit-0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/11593150-000000000-00000","article-title":"Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management","volume":"14","author":"Panetta","year":"2012","journal-title":"Paediatr Drugs"},{"key":"10.1111\/apt.12470-BIB0076|apt12470-cit-0076","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1740-2557-4-3","article-title":"The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis\/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders","volume":"4","author":"Papamichalis","year":"2007","journal-title":"J Autoimmune Dis"},{"key":"10.1111\/apt.12470-BIB0077|apt12470-cit-0077","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1478-3231.2008.01851.x","article-title":"Occult hepatitis B virus infection in Greek patients with autoimmune liver diseases","volume":"29","author":"Georgiadou","year":"2009","journal-title":"Liver Int"},{"key":"10.1111\/apt.12470-BIB0078|apt12470-cit-0078","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.dld.2010.03.005","article-title":"Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score?","volume":"42","author":"Gatselis","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1111\/apt.12470-BIB0079|apt12470-cit-0079","first-page":"233","article-title":"A new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome","volume":"6","author":"Azhar","year":"2010","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"10.1111\/apt.12470-BIB0080|apt12470-cit-0080","article-title":"Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome","author":"Rigopoulou","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1111\/apt.12470-BIB0081|apt12470-cit-0081","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3748\/wjg.15.578","article-title":"Hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"15","author":"Teufel","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0082|apt12470-cit-0082","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","article-title":"Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening","volume":"48","author":"Yeoman","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0083|apt12470-cit-0083","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.24743","article-title":"Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New Zealand","volume":"55","author":"Ngu","year":"2012","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0084|apt12470-cit-0084","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1478-3231.2011.02734.x","article-title":"Hepatocellular carcinoma and survival in patients with autoimmune hepatitis","volume":"32","author":"Migita","year":"2012","journal-title":"Liver Int"},{"key":"10.1111\/apt.12470-BIB0085|apt12470-cit-0085","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1572-0241.2008.01922.x","article-title":"Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis","volume":"103","author":"Montano-Loza","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0086|apt12470-cit-0086","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00535-011-0519-2","article-title":"Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1","volume":"47","author":"Hino-Arinaga","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0087|apt12470-cit-0087","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1365-2036.2006.03113.x","article-title":"Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis","volume":"24","author":"Miyake","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0088|apt12470-cit-0088","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MPG.0b013e3181a1c265","article-title":"Autoimmune hepatitis","volume":"49","author":"Mieli-Vergani","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1111\/apt.12470-BIB0089|apt12470-cit-0089","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0090|apt12470-cit-0090","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","author":"Gleeson","year":"2011","journal-title":"Gut"},{"key":"10.1111\/apt.12470-BIB0091|apt12470-cit-0091","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-2002-35702","article-title":"Definition and classification of autoimmune hepatitis","volume":"22","author":"McFarlane","year":"2002","journal-title":"Sem Liver Dis"},{"key":"10.1111\/apt.12470-BIB0092|apt12470-cit-0092","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510250510","article-title":"Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis","volume":"25","author":"Zauli","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0093|apt12470-cit-0093","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0094|apt12470-cit-0094","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/0891693021000054066","article-title":"Smooth muscle antibodies and type 1 autoimmune hepatitis","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1111\/apt.12470-BIB0095|apt12470-cit-0095","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/hep.510240515","article-title":"Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis","volume":"24","author":"Czaja","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0096|apt12470-cit-0096","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jcp.2005.027367","article-title":"Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis","volume":"59","author":"Granito","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1111\/apt.12470-BIB0097|apt12470-cit-0097","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.2006.039404","article-title":"Diagnostic relevance of antifilamentous actin antibodies in autoimmune hepatitis","volume":"60","author":"Liaskos","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1111\/apt.12470-BIB0098|apt12470-cit-0098","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","article-title":"Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on disease profile","volume":"26","author":"Cassani","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0099|apt12470-cit-0099","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","article-title":"Behaviour and significance of autoantibodies in type 1 autoimmune hepatitis","volume":"30","author":"Czaja","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0100|apt12470-cit-0100","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1440-1746.2012.07125.x","article-title":"Impact of pre-transplant anti-nuclear antibody (ANA) and anti-smooth muscle antibody (SMA) titers on disease recurrence and graft survival following liver transplantation in autoimmune hepatitis (AIH) patients","volume":"28","author":"Dbouk","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0101|apt12470-cit-0101","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/apt.12470-BIB0102|apt12470-cit-0102","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.30699","article-title":"Fine specificity of autoantibodies to soluble liver antigen and liver\/pancreas","volume":"35","author":"Herkel","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0103|apt12470-cit-0103","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","author":"Kanzler","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0104|apt12470-cit-0104","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(00)80361-X","article-title":"Antibodies to soluble liver antigen: an additional marker in type 1 autoimmune hepatitis","volume":"33","author":"Ballot","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0105|apt12470-cit-0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","article-title":"Establishment of standardised SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics","volume":"51","author":"Baeres","year":"2002","journal-title":"Gut"},{"key":"10.1111\/apt.12470-BIB0106|apt12470-cit-0106","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"36","author":"Ma","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0107|apt12470-cit-0107","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1572-0241.2002.05479.x","article-title":"Antibodies to soluble liver antigen\/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis","volume":"97","author":"Czaja","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0108|apt12470-cit-0108","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/liv.12022","article-title":"Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study","volume":"33","author":"Efe","year":"2013","journal-title":"Liver Int"},{"key":"10.1111\/apt.12470-BIB0109|apt12470-cit-0109","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s10620-011-2017-z","article-title":"Autoantibody-negative autoimmune hepatitis","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1111\/apt.12470-BIB0110|apt12470-cit-0110","doi-asserted-by":"crossref","first-page":"18923","DOI":"10.1073\/pnas.0609703104","article-title":"RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea","volume":"103","author":"Yuan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/apt.12470-BIB0111|apt12470-cit-0111","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.1173755","article-title":"The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation","volume":"325","author":"Palioura","year":"2009","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1111\/apt.12470-BIB0112|apt12470-cit-0112","doi-asserted-by":"crossref","first-page":"S250","DOI":"10.1016\/S0168-8278(07)62258-2","article-title":"Antibody responses specific for soluble liver antigen co-occur with Ro-52 autoantibodies in patients with autoimmune hepatitis (abstract)","volume":"46","author":"Liaskos","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0113|apt12470-cit-0113","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1478-3231.2009.01986.x","article-title":"Significance of antibodies to soluble liver antigen\/liver pancreas: a large French study","volume":"29","author":"Eyraud","year":"2009","journal-title":"Liver Int"},{"key":"10.1111\/apt.12470-BIB0114|apt12470-cit-0114","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1478-3231.2011.02502.x","article-title":"Prognostic implications of antibodies to Ro\/SSA and soluble liver antigen in type 1 autoimmune hepatitis","volume":"32","author":"Montano-Loza","year":"2012","journal-title":"Liver Int"},{"key":"10.1111\/apt.12470-BIB0115|apt12470-cit-0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1568-9972(03)00051-X","article-title":"Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis","volume":"3","author":"Fabien","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1111\/apt.12470-BIB0116|apt12470-cit-0116","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0117|apt12470-cit-0117","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1542-3565(04)00354-4","article-title":"Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody","volume":"2","author":"Bridoux-Henno","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0118|apt12470-cit-0118","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450 2D6, a cytochrome P450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1111\/apt.12470-BIB0119|apt12470-cit-0119","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1365-2249.1999.01027.x","article-title":"Overlapping but distinct specificities of anti-liver-kidney microsomes antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes","volume":"118","author":"Klein","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/apt.12470-BIB0120|apt12470-cit-0120","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0016-5085(95)90076-4","article-title":"Conformational epitopes on CYP2D6 are recognized by liver\/kidney microsomal antibodies","volume":"108","author":"Duclos-Valleye","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12470-BIB0121|apt12470-cit-0121","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0168-8278(97)80107-9","article-title":"Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C","volume":"26","author":"Nishioka","year":"1997","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0122|apt12470-cit-0122","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gut.37.3.406","article-title":"Heterogeneity of liver\/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease","volume":"37","author":"Muratori","year":"1995","journal-title":"Gut"},{"key":"10.1111\/apt.12470-BIB0123|apt12470-cit-0123","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042737-200201000-00007","article-title":"Increased incidence of anti-LKM autoantibodies in a consecutive cohort of HCV patients from central Greece","volume":"14","author":"Dalekos","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0124|apt12470-cit-0124","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1365-2036.2006.03165.x","article-title":"Clinical significance of organ and non-organ specific autoantibodies on the response to antiviral treatment of patients with chronic hepatitis C","volume":"24","author":"Gatselis","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0125|apt12470-cit-0125","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2009.02.020","article-title":"Clinical features and effects of antiviral therapy on anti-liver\/kidney microsomal antibody type1 positive chronic hepatitis C","volume":"50","author":"Ferri","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0126|apt12470-cit-0126","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/0891693021000069556","article-title":"A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens","volume":"35","author":"Sugimura","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1111\/apt.12470-BIB0127|apt12470-cit-0127","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0168-8278(03)00356-8","article-title":"Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection","volume":"39","author":"Dalekos","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0128|apt12470-cit-0128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10620-006-9495-4","article-title":"Evidence of a genetic basis for the different geographic occurrences of liver\/kidney microsomal antibody type 1 in hepatitis C","volume":"52","author":"Muratori","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1111\/apt.12470-BIB0129|apt12470-cit-0129","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0168-8278(99)80092-0","article-title":"Epitope mapping of cytochrome P450 2D6 autoantigen in patients with chronic hepatitis C under \u03b1-interferon treatment","volume":"30","author":"Dalekos","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0130|apt12470-cit-0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0168-8278(05)80395-2","article-title":"Interferon therapy in liver\/kidney microsomal antibody type 1-positive patients with chronic hepatitis C","volume":"21","author":"Muratori","year":"1994","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0131|apt12470-cit-0131","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840220506","article-title":"Efficacy and safety of interferon alpha therapy in chronic hepatitis C with autoantibodies to liver kidney microsomes","volume":"22","author":"Todros","year":"1995","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0132|apt12470-cit-0132","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.tp.0000196716.07188.c4","article-title":"Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus","volume":"81","author":"Cholongitas","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/apt.12470-BIB0133|apt12470-cit-0133","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0140-6736(05)62476-2","article-title":"Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance","volume":"350","author":"Vento","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/apt.12470-BIB0134|apt12470-cit-0134","first-page":"232","article-title":"Microsomal autoantibodies in chronic infection with HBsAg associated delta (d) agent","volume":"54","author":"Crivelli","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/apt.12470-BIB0135|apt12470-cit-0135","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2001.03383.x","article-title":"LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity","volume":"96","author":"Csepregi","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0136|apt12470-cit-0136","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.1840160407","article-title":"Characterization of liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis","volume":"16","author":"Abuaf","year":"1992","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0137|apt12470-cit-0137","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","article-title":"Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"36","author":"Lenzi","year":"1995","journal-title":"Gut"},{"key":"10.1111\/apt.12470-BIB0138|apt12470-cit-0138","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","article-title":"Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis","volume":"42","author":"Muratori","year":"1998","journal-title":"Gut"},{"key":"10.1111\/apt.12470-BIB0139|apt12470-cit-0139","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12470-BIB0140|apt12470-cit-0140","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/jhep.2001.27179","article-title":"Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1","volume":"34","author":"Muratori","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0141|apt12470-cit-0141","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-1759(95)00192-X","article-title":"Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counter immunoelectrophoresis and immunoblotting: comparison of three different techniques","volume":"187","author":"Muratori","year":"1995","journal-title":"J Immunol Methods"},{"key":"10.1111\/apt.12470-BIB0142|apt12470-cit-0142","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.ijid.2008.08.011","article-title":"Polyclonal hypergammaglobulinemia and high smooth-muscle autoantibody titers with specificity against filamentous actin: consider visceral leishmaniasis, not just autoimmune hepatitis","volume":"13","author":"Makaritsis","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1111\/apt.12470-BIB0143|apt12470-cit-0143","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12016-007-8050-1","article-title":"Anti-alpha-actinin antibodies cross-react with anti-ssDNA antibodies in active autoimmune hepatitis","volume":"34","author":"Renaudineau","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1111\/apt.12470-BIB0144|apt12470-cit-0144","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaut.2005.01.016","article-title":"Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis","volume":"24","author":"Liaskos","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1111\/apt.12470-BIB0145|apt12470-cit-0145","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1440-1746.1998.tb00673.x","article-title":"Characterization of antihistone antibodies in patients with type 1 autoimmune hepatitis","volume":"13","author":"Chen","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0146|apt12470-cit-0146","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/08916930600783348","article-title":"Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis","volume":"39","author":"Montano-Loza","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1111\/apt.12470-BIB0147|apt12470-cit-0147","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-2036.2005.02686.x","article-title":"Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis","volume":"22","author":"Fusconi","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0148|apt12470-cit-0148","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2009.06.035","article-title":"Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA-revival of a disease-activity marker in autoimmune hepatitis","volume":"408","author":"Hausdorf","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1111\/apt.12470-BIB0149|apt12470-cit-0149","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1023\/A:1024748714580","article-title":"Frequency and significance of antibodies to chromatin in autoimmune hepatitis","volume":"48","author":"Czaja","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1111\/apt.12470-BIB0150|apt12470-cit-0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","article-title":"Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis","volume":"139","author":"Czaja","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12470-BIB0151|apt12470-cit-0151","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","article-title":"Antibodies to SS-A\/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis","volume":"26","author":"Granito","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0152|apt12470-cit-0152","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10875-006-9045-z","article-title":"Double reactivity against actin and \u03b1-actinin defines a severe form of autoimmune hepatitis type 1","volume":"26","author":"Gueguen","year":"2006","journal-title":"J Clin Immunol"},{"key":"10.1111\/apt.12470-BIB0153|apt12470-cit-0153","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.autrev.2010.12.009","article-title":"Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity","volume":"10","author":"Oikonomou","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1111\/apt.12470-BIB0154|apt12470-cit-0154","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2036.2011.04908.x","article-title":"Anti-\u03b1 actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1","volume":"35","author":"Zachou","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0155|apt12470-cit-0155","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2249.2003.02166.x","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases","volume":"132","author":"Muratori","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/apt.12470-BIB0156|apt12470-cit-0156","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1023\/B:DDAS.0000026306.36511.c8","article-title":"Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis","volume":"49","author":"Czaja","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1111\/apt.12470-BIB0157|apt12470-cit-0157","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1517\/17530059.2.6.621","article-title":"Molecular diagnostics of primary biliary cirrhosis","volume":"2","author":"Rigopoulou","year":"2008","journal-title":"Expert Opin Med Diagn"},{"key":"10.1111\/apt.12470-BIB0158|apt12470-cit-0158","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1440-1746.2006.04434.x","article-title":"Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis","volume":"21","author":"Nezu","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0159|apt12470-cit-0159","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1440-1746.2006.04751.x","article-title":"Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact?","volume":"22","author":"Liaskos","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0160|apt12470-cit-0160","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","article-title":"Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis","volume":"42","author":"Montano-Loza","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0161|apt12470-cit-0161","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O'Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0162|apt12470-cit-0162","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cgh.2012.02.010","article-title":"Patients with autoimmune hepatitis who have antimitochondrial antibodies need long-term follow-up to detect late development of primary biliary cirrhosis","volume":"10","author":"Dinani","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0163|apt12470-cit-0163","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1365-2249.2001.01524.x","article-title":"Antilactoferrin antibodies in autoimmune liver disease","volume":"124","author":"Muratori","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/apt.12470-BIB0164|apt12470-cit-0164","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1155\/2012\/890698","article-title":"Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases","volume":"26","author":"Himoto","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0165|apt12470-cit-0165","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","article-title":"\u2018True\u2019 antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?","volume":"135","author":"Muratori","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/apt.12470-BIB0166|apt12470-cit-0166","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.autrev.2007.02.001","article-title":"Anti-alpha-actinin antibodies: a new marker of lupus nephritis","volume":"6","author":"Renaudineau","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1111\/apt.12470-BIB0167|apt12470-cit-0167","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-8411(03)00036-2","article-title":"Fine specificity and subclasses of IgG anti-actin autoantibodies differ in health and disease","volume":"20","author":"Zamanou","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1111\/apt.12470-BIB0168|apt12470-cit-0168","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11894-011-0236-2","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"14","author":"Vierling","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1111\/apt.12470-BIB0169|apt12470-cit-0169","first-page":"99","article-title":"Anti-asialoglycoprotein receptor autoantibodies, detected by a capture-immunoassay, are associated with autoimmune liver diseases","volume":"56","author":"Yoshioka","year":"2002","journal-title":"Acta Med Okayama"},{"key":"10.1111\/apt.12470-BIB0170|apt12470-cit-0170","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.20172","article-title":"Asialoglycoprotein receptor facilitates hemolysis in patients with alcoholic liver cirrhosis","volume":"39","author":"Hilgard","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0171|apt12470-cit-0171","first-page":"7","article-title":"Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients","volume":"45","author":"Husa","year":"2001","journal-title":"Acta Virol"},{"key":"10.1111\/apt.12470-BIB0172|apt12470-cit-0172","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cgh.2010.07.016","article-title":"Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis","volume":"9","author":"Bjornsson","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0173|apt12470-cit-0173","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1478-3231.2004.0924.x","article-title":"Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis","volume":"24","author":"Czaja","year":"2004","journal-title":"Liver Int"},{"key":"10.1111\/apt.12470-BIB0174|apt12470-cit-0174","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1089-3261(02)00007-7","article-title":"Autoimmune hepatitis and overlap syndromes","volume":"6","author":"Dienes","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1111\/apt.12470-BIB0175|apt12470-cit-0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/gut.41.2.269","article-title":"Autoimmune hepatitis: a histological variant associated with prominent centrilobular necrosis","volume":"41","author":"Te","year":"1997","journal-title":"Gut"},{"key":"10.1111\/apt.12470-BIB0176|apt12470-cit-0176","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00535-008-2254-x","article-title":"Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis","volume":"43","author":"Fujiwara","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0177|apt12470-cit-0177","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cld.2010.07.003","article-title":"Histology of autoimmune hepatitis and its variants","volume":"14","author":"Guindi","year":"2010","journal-title":"Clin Liver Dis"},{"key":"10.1111\/apt.12470-BIB0178|apt12470-cit-0178","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00535-010-0316-3","article-title":"Clinicopathological features of severe and fulminant forms of autoimmune hepatitis","volume":"46","author":"Yasui","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0179|apt12470-cit-0179","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3748\/wjg.14.3368","article-title":"Overlap syndromes among autoimmune liver diseases","volume":"14","author":"Rust","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0180|apt12470-cit-0180","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0181|apt12470-cit-0181","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/0891693021000064272","article-title":"The hepatitic\/cholestatic \u201coverlap\u201d syndrome: an Italian experience","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1111\/apt.12470-BIB0182|apt12470-cit-0182","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0183|apt12470-cit-0183","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2009.616","article-title":"Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis","volume":"105","author":"Neuhauser","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0184|apt12470-cit-0184","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cgh.2010.03.004","article-title":"Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome","volume":"8","author":"Kuiper","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0185|apt12470-cit-0185","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0186|apt12470-cit-0186","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/ajg.2009.126","article-title":"The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome","volume":"104","author":"Muratori","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0187|apt12470-cit-0187","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1665-2681(19)31583-2","article-title":"Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis\/primary biliary cirrhosis (AIH-PBC) from those with autoimmune hepatitis type 1?","volume":"10","author":"Coss","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.1111\/apt.12470-BIB0188|apt12470-cit-0188","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1309\/AJCPE93GZSHUNTAI","article-title":"The usefulness of IgG and IgM immunostaining of periportal inflammatory cells (plasma cells and lymphocytes) for the distinction of autoimmune hepatitis and primary biliary cirrhosis and their staining pattern in autoimmune hepatitis-primary biliary cirrhosis overlap syndrome","volume":"133","author":"Lee","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/apt.12470-BIB0189|apt12470-cit-0189","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.dld.2009.12.006","article-title":"Intrahepatic IgG\/IgM plasma cells ratio helps in classifying autoimmune liver diseases","volume":"42","author":"Cabibi","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1111\/apt.12470-BIB0190|apt12470-cit-0190","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/apt.12470-BIB0191|apt12470-cit-0191","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.21700","article-title":"Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis","volume":"46","author":"Umemura","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0192|apt12470-cit-0192","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1478-3231.2009.02092.x","article-title":"Identification and characterization of IgG4-associated autoimmune hepatitis","volume":"30","author":"Chung","year":"2010","journal-title":"Liver Int"},{"issue":"Suppl. 1","key":"10.1111\/apt.12470-BIB0193|apt12470-cit-0193","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00535-010-0323-4","article-title":"Clinical significance of immunoglobulin G4-associated autoimmune hepatitis","volume":"46","author":"Umemura","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0194|apt12470-cit-0194","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2036.2012.05223.x","article-title":"Review article: overlap syndromes and autoimmune liver disease","volume":"36","author":"Trivedi","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0195|apt12470-cit-0195","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bpg.2011.10.004","article-title":"Diagnostic criteria for autoimmune hepatitis","volume":"25","author":"Lohse","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0196|apt12470-cit-0196","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/hep.22825","article-title":"Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients","volume":"49","author":"Muratori","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0197|apt12470-cit-0197","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.23042","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease","volume":"50","author":"Yeoman","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0198|apt12470-cit-0198","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.dld.2009.06.013","article-title":"Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group","volume":"42","author":"Miyake","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1111\/apt.12470-BIB0199|apt12470-cit-0199","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1053\/j.gastro.2011.02.010","article-title":"Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria","volume":"140","author":"Czaja","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12470-BIB0200|apt12470-cit-0200","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1478-3231.2011.02524.x","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis","volume":"31","author":"Fujiwara","year":"2011","journal-title":"Liver Int"},{"key":"10.1111\/apt.12470-BIB0201|apt12470-cit-0201","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2010.06.032","article-title":"Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients","volume":"54","author":"Qiu","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0202|apt12470-cit-0202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jhep.2010.07.013","article-title":"Recognizing autoimmune hepatitis: scores help, but no more","volume":"54","author":"Lohse","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0203|apt12470-cit-0203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","author":"Cook","year":"1971","journal-title":"Q J Med"},{"key":"10.1111\/apt.12470-BIB0204|apt12470-cit-0204","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12470-BIB0205|apt12470-cit-0205","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"key":"10.1111\/apt.12470-BIB0206|apt12470-cit-0206","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gut.21.1.78","article-title":"Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis","volume":"21","author":"Kirk","year":"1980","journal-title":"Gut"},{"key":"10.1111\/apt.12470-BIB0207|apt12470-cit-0207","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jhep.2010.12.012","article-title":"Autoimmune hepatitis","volume":"55","author":"Lohse","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0208|apt12470-cit-0208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2036.2003.01389.x","article-title":"Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis","volume":"17","author":"Medina","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0209|apt12470-cit-0209","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/hep.23840","article-title":"Treatment response in patients with autoimmune hepatitis","volume":"52","author":"Schramm","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0210|apt12470-cit-0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.2011.04690.x","article-title":"Early normalisation of aminotransferase predicts complete biochemical remission in autoimmune hepatitis patients","volume":"34","author":"Wang","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0211|apt12470-cit-0211","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/apt.12042","article-title":"Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs","volume":"36","author":"Selvarajah","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0212|apt12470-cit-0212","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/hep.23924","article-title":"Application of the 2010 American Association for the Study of Liver Diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis","volume":"52","author":"Muratori","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0213|apt12470-cit-0213","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2036.2010.04241.x","article-title":"Review article: the modern management of autoimmune hepatitis","volume":"31","author":"Yeoman","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0214|apt12470-cit-0214","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for long-term maintenance of remission in autoimmune hepatitis","volume":"333","author":"Johnson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/apt.12470-BIB0215|apt12470-cit-0215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","article-title":"Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials","volume":"53","author":"Lamers","year":"2010","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0216|apt12470-cit-0216","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14740338.7.3.319","article-title":"Safety issues in the management of autoimmune hepatitis","volume":"7","author":"Czaja","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/apt.12470-BIB0217|apt12470-cit-0217","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00228-008-0478-6","article-title":"Clinical pharmacology and pharmacogenetics of thiopurines","volume":"64","author":"Sahasranaman","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/apt.12470-BIB0218|apt12470-cit-0218","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1478-3231.2006.01392.x","article-title":"Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases","volume":"27","author":"Tamori","year":"2007","journal-title":"Liver Int"},{"key":"10.1111\/apt.12470-BIB0219|apt12470-cit-0219","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/egh.09.15","article-title":"Current and future treatments of autoimmune hepatitis","volume":"3","author":"Czaja","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0220|apt12470-cit-0220","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0221|apt12470-cit-0221","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"Gerven","year":"2013","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0222|apt12470-cit-0222","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.dld.2010.05.019","article-title":"Current topics in autoimmune hepatitis","volume":"42","author":"Muratori","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1111\/apt.12470-BIB0223|apt12470-cit-0223","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1007\/s10620-009-1122-8","article-title":"Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis","volume":"55","author":"Czaja","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1111\/apt.12470-BIB0224|apt12470-cit-0224","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/apt.12223","article-title":"Allopurinol safely and effectively optimizes thiopurine metabolites in patients with autoimmune hepatitis","volume":"37","author":"Boer","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0225|apt12470-cit-0225","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(99)80065-8","article-title":"Short-term cyclosporine induces a remission of autoimmune hepatitis in children","volume":"30","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0226|apt12470-cit-0226","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2036.2003.01754.x","article-title":"Effectiveness and safety of cyclosporine as therapy for autoimmune diseases of the liver in children and adolescents","volume":"19","author":"Sciveres","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0227|apt12470-cit-0227","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1651-2227.2012.02745.x","article-title":"Tacrolimus without or with the addition of conventional immunosuppressive treatment in juvenile autoimmune hepatitis","volume":"101","author":"Marlaka","year":"2012","journal-title":"Acta Paediatr"},{"key":"10.1111\/apt.12470-BIB0228|apt12470-cit-0228","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2036.2011.04749.x","article-title":"Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience","volume":"34","author":"Tannous","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0229|apt12470-cit-0229","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1177\/096120330501400102","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus"},{"key":"10.1111\/apt.12470-BIB0230|apt12470-cit-0230","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.autrev.2006.11.001","article-title":"Mycophenolate mofetil: What is its place in the treatment of autoimmune rheumatic diseases?","volume":"6","author":"Iaccarino","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1111\/apt.12470-BIB0231|apt12470-cit-0231","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(00)80271-8","article-title":"Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine","volume":"33","author":"Richardson","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0232|apt12470-cit-0232","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1155\/2004\/504591","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy","volume":"18","author":"Devlin","year":"2004","journal-title":"Can J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0233|apt12470-cit-0233","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1478-3231.2005.01107.x","article-title":"Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus","volume":"25","author":"Chatur","year":"2005","journal-title":"Liver Int"},{"key":"10.1111\/apt.12470-BIB0234|apt12470-cit-0234","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cgh.2007.02.030","article-title":"Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy","volume":"5","author":"Inductivo-Yu","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0235|apt12470-cit-0235","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","article-title":"Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up","volume":"51","author":"Aw","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0236|apt12470-cit-0236","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s10620-008-0632-0","article-title":"Mycophenolate Mofetil for autoimmune hepatitis: a single practice experience","volume":"54","author":"Wolf","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1111\/apt.12470-BIB0237|apt12470-cit-0237","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.mcg.0000177260.72692.e8","article-title":"Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease","volume":"39","author":"Czaja","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0238|apt12470-cit-0238","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0239|apt12470-cit-0239","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1155\/2010\/891252","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy","volume":"24","author":"Sharzehi","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0240|apt12470-cit-0240","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2036.2011.04727.x","article-title":"The role of mycophenolate in the management of autoimmune hepatitis and overlap syndromes","volume":"34","author":"Baven-Pronk","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0241|apt12470-cit-0241","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","article-title":"A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis","volume":"6","author":"Hlivko","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0242|apt12470-cit-0242","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jhep.2009.02.026","article-title":"Rapidity of treatment response and outcome in type 1 autoimmune hepatitis","volume":"51","author":"Czaja","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0243|apt12470-cit-0243","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2036.1994.tb00334.x","article-title":"Oral budesonide for treatment of autoimmune chronic active hepatitis","volume":"8","author":"Danielson","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0244|apt12470-cit-0244","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12470-BIB0245|apt12470-cit-0245","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.2174\/138161211798157568","article-title":"Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis","volume":"17","author":"Czaja","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1111\/apt.12470-BIB0246|apt12470-cit-0246","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jhep.2010.09.017","article-title":"Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment","volume":"54","author":"Lohse","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0247|apt12470-cit-0247","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1365-2036.2008.03782.x","article-title":"Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease","volume":"28","author":"Ansari","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0248|apt12470-cit-0248","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/hep.25760","article-title":"Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis","volume":"56","author":"Dhaliwal","year":"2012","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0249|apt12470-cit-0249","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/hep.26198","article-title":"Use of a xanthine oxidase inhibitor in autoimmune hepatitis","volume":"57","author":"Al-Shamma","year":"2013","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0250|apt12470-cit-0250","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00404-010-1540-z","article-title":"Pregnancy outcome in women with autoimmune hepatitis","volume":"284","author":"Aggarwal","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1111\/apt.12470-BIB0251|apt12470-cit-0251","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MCG.0b013e318176b8c5","article-title":"Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes","volume":"43","author":"Terrabuio","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0252|apt12470-cit-0252","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ajg.2012.430","article-title":"Safety of thiopurines and anti-TNF-\u03b1 drugs during pregnancy in patients with inflammatory bowel disease","volume":"108","author":"Casanova","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0253|apt12470-cit-0253","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.mpg.0000239735.87111.ba","article-title":"Prospective analysis of nonadherence in autoimmune hepatitis: a common problem","volume":"43","author":"Kerkar","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1111\/apt.12470-BIB0254|apt12470-cit-0254","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2012.07.032","article-title":"Identifying opportunities to improve management of autoimmune hepatitis: evaluation of drug adherence and psychosocial factors","volume":"57","author":"Sockalingam","year":"2012","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0255|apt12470-cit-0255","first-page":"326","article-title":"The overlap syndromes of autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1111\/apt.12470-BIB0256|apt12470-cit-0256","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/apt.12470-BIB0257|apt12470-cit-0257","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.25682","article-title":"The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway","volume":"56","author":"Liberal","year":"2012","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0258|apt12470-cit-0258","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0259|apt12470-cit-0259","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.22071","article-title":"Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis","volume":"47","author":"Longhi","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0260|apt12470-cit-0260","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/hep.24039","article-title":"Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis","volume":"53","author":"Longhi","year":"2011","journal-title":"Hepatology"},{"key":"10.1111\/apt.12470-BIB0261|apt12470-cit-0261","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2012.02.041","article-title":"Inhibition of interleukin-17 promotes differentiation of CD25(-) cells into stable T regulatory cells in patients with autoimmune hepatitis","volume":"142","author":"Longhi","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12470-BIB0262|apt12470-cit-0262","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1111\/apt.12470-BIB0263|apt12470-cit-0263","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1172\/JCI27191","article-title":"Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs","volume":"116","author":"Bresson","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/apt.12470-BIB0264|apt12470-cit-0264","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/TP.0b013e31819d2032","article-title":"Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+Foxp3+ regulatory T cells","volume":"87","author":"Demirkiran","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/apt.12470-BIB0265|apt12470-cit-0265","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1016\/j.transproceed.2012.09.091","article-title":"Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil","volume":"44","author":"Miroux","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1111\/apt.12470-BIB0266|apt12470-cit-0266","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cyto.2008.06.006","article-title":"Mycophenolate mofetil promotes down-regulation of expanded B cells and production of TNF-alpha in an experimental murine model of colitis","volume":"44","author":"Lee","year":"2008","journal-title":"Cytokine"},{"key":"10.1111\/apt.12470-BIB0267|apt12470-cit-0267","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trim.2012.05.001","article-title":"Immunosuppressive drugs on inducing Ag-specific CD4+CD25+Foxp3+ Treg cells during immune response in vivo","volume":"27","author":"Wu","year":"2012","journal-title":"Transpl Immunol"},{"key":"10.1111\/apt.12470-BIB0268|apt12470-cit-0268","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0140-6736(05)64700-9","article-title":"Resolution of autoimmune hepatitis after bone-marrow transplantation","volume":"348","author":"Vento","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/apt.12470-BIB0269|apt12470-cit-0269","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0168-8278(03)00387-8","article-title":"Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis","volume":"39","author":"Kyriakou","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0270|apt12470-cit-0270","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1111\/j.1440-1746.2008.05309.x","article-title":"Bone marrow findings in patients with autoimmune liver diseases","volume":"23","author":"Tsikrikoni","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/apt.12470-BIB0271|apt12470-cit-0271","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jhep.2004.11.023","article-title":"Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis","volume":"42","author":"Tsikrikoni","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0272|apt12470-cit-0272","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaut.2005.08.002","article-title":"Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production","volume":"25","author":"Zachou","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1111\/apt.12470-BIB0273|apt12470-cit-0273","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1053\/j.gastro.2008.03.015","article-title":"Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells","volume":"134","author":"Kuo","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/apt.12470-BIB0274|apt12470-cit-0274","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.tp.0000194860.21533.b9","article-title":"Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells","volume":"81","author":"Nikolaeva","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/apt.12470-BIB0275|apt12470-cit-0275","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4049\/jimmunol.178.1.320","article-title":"Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin","volume":"178","author":"Strauss","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/apt.12470-BIB0276|apt12470-cit-0276","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","article-title":"Rapamycin successfully treats post-transplant autoimmune hepatitis","volume":"5","author":"Kerkar","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/apt.12470-BIB0277|apt12470-cit-0277","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000322693","article-title":"Case of autoimmune hepatitis treated with rituximab","volume":"4","author":"Barth","year":"2010","journal-title":"Case Rep Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0278|apt12470-cit-0278","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MOH.0b013e32834da987","article-title":"Neutropenia after rituximab treatment: new insights on a late complication","volume":"19","author":"Wolach","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/apt.12470-BIB0279|apt12470-cit-0279","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1478-3231.2011.02452.x","article-title":"Hepatitis B re-activation with rituximab therapy: treat the patient not the disease","volume":"31","author":"Zachou","year":"2011","journal-title":"Liver Int"},{"key":"10.1111\/apt.12470-BIB0280|apt12470-cit-0280","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4254\/wjh.v5.i7.387","article-title":"Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: a hidden threat","volume":"5","author":"Zachou","year":"2013","journal-title":"World J hepatol"},{"key":"10.1111\/apt.12470-BIB0281|apt12470-cit-0281","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clim.2012.10.008","article-title":"TNF-\u03b1 is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression","volume":"146","author":"Iwamoto","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1111\/apt.12470-BIB0282|apt12470-cit-0282","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: a comprehensive review","volume":"41","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1111\/apt.12470-BIB0283|apt12470-cit-0283","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0284|apt12470-cit-0284","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/BOR.0b013e32835b1366","article-title":"Biologics-induced autoimmune diseases","volume":"25","author":"Perez-Alvarez","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/apt.12470-BIB0285|apt12470-cit-0285","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.02.029","article-title":"Use of TNF\u03b1 antagonists in refractory AIH: revealing the unforeseen","volume":"59","author":"Saitis","year":"2013","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0286|apt12470-cit-0286","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jhep.2012.04.005","article-title":"Regulatory T cells and autoimmune hepatitis: defective cells or a hostile environment?","volume":"57","author":"Oo","year":"2012","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12470-BIB0287|apt12470-cit-0287","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2013.06.016","article-title":"The interplay between regulatory and effector T cells in autoimmune hepatitis: implications for innovative treatment strategies","author":"Muratori","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1111\/apt.12470-BIB0288|apt12470-cit-0288","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases","volume":"25","author":"Ilyas","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1111\/apt.12470-BIB0289|apt12470-cit-0289","first-page":"461","article-title":"Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry","volume":"16","author":"Schramm","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1111\/apt.12470-BIB0290|apt12470-cit-0290","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2004.00117.x","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis","volume":"18","author":"Vogel","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1111\/apt.12470-BIB0291|apt12470-cit-0291","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation","volume":"15","author":"Montano-Loza","year":"2009","journal-title":"Liver Transpl"}],"container-title":["Alimentary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.12470","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/apt.12470\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:08:18Z","timestamp":1715969298000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.12470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,8]]},"references-count":291,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,10]]}},"URL":"https:\/\/doi.org\/10.1111\/apt.12470","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,8]]}}}